Elevated COX-2 expression in cervical carcinoma: Reduced cause-specific survival and pelvic control

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 24, Issue 5, 2001, Pages 443-446

  Gaffney, David K ^a,c   Holden, Joseph ^a,c   Zempolich, Karen ^a,c   Murphy, Kelley J ^b,c   Dicker, Adam P ^c   Dodson, Mark ^a,c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Cervical cancer; COX 2 (cyclooxygenase 2); Local control; Radiation therapy

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; FORMALDEHYDE; PARAFFIN;

ARTICLE; CANCER CONTROL; CANCER GRADING; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HEMOGLOBIN DETERMINATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PATHOPHYSIOLOGY; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RADIATION DOSE; RADIOSENSITIZATION; STATISTICAL ANALYSIS; SURVIVAL RATE; TREATMENT FAILURE; TUMOR BIOPSY; UTERINE CERVIX CARCINOMA;

CYCLOOXYGENASE 2; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MEMBRANE PROTEINS; NEOPLASM STAGING; PROGNOSIS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS; TREATMENT FAILURE; UTERINE CERVICAL NEOPLASMS;

EID: 0034787826     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200110000-00006     Document Type: Article

References (17)

1. Cancer statistics, 2001
2. Expression of p27 and p53 in cervical squamous cell carcinoma patients treated with radiotherapy alone: Radiotherapeutic effect and prognosis
3. Disease control of uterine cervical cancer: Relationships to tumor oxygen tension, vascular density, cell density, and frequency of mitosis and apoptosis measured before treatment and during radiotherapy
4. Interstitial fluid pressure in cervical carcinoma: Within tumor heterogeneity, and relation to oxygen tension
5. High cyclooxygenase-2 expression in stage IB cervical cancer with lymph node metastasis or parametrial invasion
6. Elevated cyclooxygenase-2 expression correlates with diminished survival in carcinoma of the cervix treated with radiotherapy
7. COX-2 is expressed in human pulmonary, colonic, and mammary tumors
8. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors
9. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: Independence from COX-2 protein expression
10. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase-2
11. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
12. Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme
13. Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor
14. Host cyclooxygenase-2 modulates carcinoma growth
15. Cyclooxygenase-2 expression differs among vulvar dysplasia and carcinoma
16. Radiation induces upregulation of cyclooxygenase-2 (COX-2) protein in PC-3 cells